ME02326B - Rekonstituisani surfaktanti sa poboljšanim svojstvima - Google Patents

Rekonstituisani surfaktanti sa poboljšanim svojstvima

Info

Publication number
ME02326B
ME02326B MEP-2016-20A MEP2016A ME02326B ME 02326 B ME02326 B ME 02326B ME P2016 A MEP2016 A ME P2016A ME 02326 B ME02326 B ME 02326B
Authority
ME
Montenegro
Prior art keywords
improved properties
reconstituted surfactants
reconstituted
surfactants
properties
Prior art date
Application number
MEP-2016-20A
Other languages
English (en)
Inventor
Per-Ola Mikael Johansson
Tore Curstedt
Bengt Robertson
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME02326(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of ME02326B publication Critical patent/ME02326B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
MEP-2016-20A 2006-10-13 2007-09-28 Rekonstituisani surfaktanti sa poboljšanim svojstvima ME02326B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13
EP07825212.9A EP2078038B1 (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties
PCT/IB2007/002841 WO2008044109A1 (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties

Publications (1)

Publication Number Publication Date
ME02326B true ME02326B (me) 2016-06-20

Family

ID=39079026

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-2016-20A ME02326B (me) 2006-10-13 2007-09-28 Rekonstituisani surfaktanti sa poboljšanim svojstvima
MEP-121/09A MEP12109A (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-121/09A MEP12109A (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties

Country Status (36)

Country Link
US (2) US8183210B2 (me)
EP (1) EP2078038B1 (me)
JP (2) JP5405307B2 (me)
KR (1) KR101328851B1 (me)
CN (2) CN101522711B (me)
AR (2) AR063263A1 (me)
AU (1) AU2007306075B2 (me)
BR (1) BRPI0715317B1 (me)
CA (1) CA2666344C (me)
CL (1) CL2007002931A1 (me)
CO (1) CO6400235A2 (me)
CY (1) CY1114716T1 (me)
DK (1) DK2078038T3 (me)
EA (1) EA015802B1 (me)
ES (1) ES2438727T3 (me)
GE (1) GEP20125531B (me)
HK (2) HK1134497A1 (me)
HR (1) HRP20140052T1 (me)
IL (1) IL198075A (me)
JO (1) JO2963B1 (me)
MA (1) MA31062B1 (me)
ME (2) ME02326B (me)
MX (1) MX343064B (me)
MY (1) MY148127A (me)
NO (1) NO342038B1 (me)
NZ (1) NZ576189A (me)
PE (1) PE20081184A1 (me)
PL (1) PL2078038T3 (me)
PT (1) PT2078038E (me)
RS (1) RS53172B (me)
SI (1) SI2078038T1 (me)
TN (1) TN2009000099A1 (me)
TW (1) TWI388333B (me)
UA (1) UA94477C2 (me)
WO (1) WO2008044109A1 (me)
ZA (1) ZA200902481B (me)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2658478C (en) 2006-07-20 2018-02-13 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
EP2812018B1 (en) 2012-02-09 2018-12-05 University Of Rochester Novel sp-b&sp-c peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
CN104812771B (zh) * 2012-11-21 2018-03-30 奇斯药制品公司 重建的肺表面活性剂
CA3008646A1 (en) 2015-12-17 2017-06-22 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Synthetic lung surfactant with enhanced stability and effectiveness
CA3016810C (en) 2016-03-07 2024-04-02 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for administering ppar.gamma. agonists, surfactant peptides and phospholipids
CA3029456A1 (en) * 2016-08-24 2018-03-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical formulation comprising a reconstituted pulmonary surfactant composition
EP4097128A1 (en) 2020-01-28 2022-12-07 Chiesi Farmaceutici S.p.A. Polypeptides having improved properties

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0706374B1 (en) * 1993-06-30 1997-12-10 Genentech, Inc. Method for preparing liposomes
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
CA2658478C (en) * 2006-07-20 2018-02-13 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
US20130079275A1 (en) 2013-03-28
TN2009000099A1 (en) 2010-08-19
JO2963B1 (en) 2016-03-15
US8183210B2 (en) 2012-05-22
EA015802B1 (ru) 2011-12-30
ZA200902481B (en) 2010-07-28
EA200900373A1 (ru) 2009-10-30
BRPI0715317A2 (pt) 2013-07-09
CY1114716T1 (el) 2016-10-05
HRP20140052T1 (hr) 2014-02-28
WO2008044109A1 (en) 2008-04-17
MY148127A (en) 2013-02-28
GEP20125531B (en) 2012-05-25
KR20090083892A (ko) 2009-08-04
PL2078038T3 (pl) 2014-05-30
CL2007002931A1 (es) 2008-03-24
MX343064B (es) 2016-10-24
CN101522711B (zh) 2013-11-13
CN103169947B (zh) 2014-10-29
CO6400235A2 (es) 2012-03-15
DK2078038T3 (da) 2013-12-02
AU2007306075A1 (en) 2008-04-17
AU2007306075B2 (en) 2012-08-09
CN101522711A (zh) 2009-09-02
AR063263A1 (es) 2009-01-14
SI2078038T1 (sl) 2014-02-28
NO20091441L (no) 2009-06-23
US9238058B2 (en) 2016-01-19
IL198075A0 (en) 2011-08-01
TW200824705A (en) 2008-06-16
NO342038B1 (no) 2018-03-19
PT2078038E (pt) 2013-12-12
CA2666344C (en) 2017-04-18
KR101328851B1 (ko) 2013-11-14
RS53172B (en) 2014-06-30
HK1134497A1 (en) 2010-04-30
IL198075A (en) 2016-04-21
EP2078038A1 (en) 2009-07-15
CN103169947A (zh) 2013-06-26
JP2010505937A (ja) 2010-02-25
JP5405307B2 (ja) 2014-02-05
AR113422A2 (es) 2020-04-29
MEP12109A (en) 2011-12-20
NZ576189A (en) 2011-09-30
US20100004173A1 (en) 2010-01-07
CA2666344A1 (en) 2008-04-17
EP2078038B1 (en) 2013-11-20
UA94477C2 (ru) 2011-05-10
MA31062B1 (fr) 2010-01-04
BRPI0715317B1 (pt) 2021-10-05
ES2438727T3 (es) 2014-01-20
PE20081184A1 (es) 2008-09-26
HK1185274A1 (en) 2014-02-14
MX2009003638A (es) 2009-04-22
TWI388333B (zh) 2013-03-11
JP2013241449A (ja) 2013-12-05

Similar Documents

Publication Publication Date Title
HK1185274A1 (en) Reconstituted surfactants having improved properties
HK1109088A1 (en) Solubilization preparation
PL1849352T3 (pl) Kombajn
IL179238A0 (en) Improved prebiotic
EP2084349A4 (en) SNAP
PL1854805T3 (pl) Pochodzące z kawy surfaktanty
GB0612542D0 (en) Combinations comprising staurosporines
EP1988197A4 (en) STEREOSCOPIC KNIT
ZA200903041B (en) Combination
GB0609530D0 (en) Combination
GB0609619D0 (en) Combination
EP2119446A4 (en) EPITHELVERSTÄRKUNGSMITTEL
HK1147652A1 (en) Flavor improving agent
GB0519871D0 (en) Immunogenic agents
EP2066601A4 (en) HYDROSILYLATION
GB0714623D0 (en) Enhanced messaging
GB2437739B (en) Latch
GB0625861D0 (en) Modified flexicast/flexisplint
GB0524433D0 (en) Contents-relating arrangements
GB2431102B (en) Vessel-filling arrangements
GB0609983D0 (en) W w w
GB0611920D0 (en) W w w
GB0609838D0 (en) W w w
GB0609731D0 (en) W w w
GB0609687D0 (en) Corcost 5b